Search
UTSW finds potential key to predict immunotherapy toxicity : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/aug-immunotherapy-toxicity.html
Researchers at UT Southwestern Medical Center have identified a novel parameter of T cells that could help oncologists anticipate which patients would be most likely to develop immunotherapy toxicity.
Genetic mutation could worsen heart function in Duchenne muscular dystrophy patients : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/genetic-mutation.html
A mutation in the gene that causes cystic fibrosis may accelerate heart function decline in those with Duchenne muscular dystrophy (DMD), a new study by UT Southwestern researchers suggests.
Keep food in the safety zone: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/food-safety.html
Avoid food poisoning with a few cautionary steps
Singers’ genre may play role in voice injuries: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2022/december-voice-injuries.html
A singer’s primary genre can impact the likelihood of developing vocal fold injury and may even influence the specific type of injury that occurs, a recent study by UT Southwestern researchers suggests.
Daniel Siegwart, Ph.D., named fellow of the National Academy of Inventors: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-siegwart-nai.html
Daniel Siegwart, Ph.D., Professor in the Departments of Biomedical Engineering and Biochemistry and in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center, has been selected as a fellow of the National Academy of Inventors (NAI) in recognition of his efforts in
In Memoriam: David J. Mangelsdorf, Ph.D., pioneer in orphan nuclear receptor research and Chair of Pharmacology
https://www.utsouthwestern.edu/newsroom/articles/year-2025/aug-mangelsdorf.html
In Memoriam: David J. Mangelsdorf, Ph.D., pioneer in orphan nuclear receptor research and Chair of Pharmacology Published on: August 09, 2025 • By: Newsroom Share Share on Facebook Share on Twitter Share on LinkedIn Email this page Print this page DALLAS – Aug. 9, 2025 – David J. Mangelsdorf, Ph.D., Chair and Professor of Pharmacology at UT Southwestern Medical Center, a visionary scientist who pioneered the once-obscure realm of orphan nuclear receptors (a class of proteins involved in gene
UTSW Research: Alcohol-associated liver disease, depression treatment, and more: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/sept-research-roundup.html
Researchers have long known that outcomes for alcohol-associated liver disease (ALD) aren’t equal among all races and ethnicities in the U.S., but differences among these groups have been less clear.
Hypnosis through virtual reality aids in medical recovery: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/virtual-reality.html
Anesthesiologists are exploring the use of hypnosis through virtual reality to lessen postoperative pain and anxiety in children.
Novel microscopy method at UT Southwestern provides look into future of cell biology: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/novel-microscopy-method.html
What if a microscope allowed us to explore the 3D microcosm of blood vessels, nerves, and cancer cells instantaneously in virtual reality?
Patient Notification: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-media-statement.html
UT Southwestern Medical Center is notifying individuals whose data may have been inappropriately disclosed; however, UT Southwestern has received no indication that the information has been used inappropriately.